Heidelberg, Germany – Heidelberg Engineering will offer a preview of its cataract and refractive imaging platform* during this year’s Congress of the ESCRS in Barcelona. The platform is based on an upgradable, modular design, which allows to configure each product to the specific diagnostic workflow in a practice or clinic. Main options include: IOL biometry, corneal topography/tomography, anterior segment biometry and anterior segment imaging.
The new platform is based on swept-source OCT technology. An important characteristic of the new platform is the fact that all measurements and analysis are based on high-resolution diagnostic images. This mitigates the effects of confounding factors such as coexisting abnormalities, which often cannot unambiguously be identified without diagnostic imaging. The new approach increases ophthalmologists’ confidence in the measurements.
“You actually see what you measure and measure what you see”, summarizes Dr. Kester Nahen, Managing Director of Heidelberg Engineering. “We are presenting a single, user-friendly device with biometry, corneal topography and tomography as well as anterior imaging functions which is bound to enhance productivity. Productivity is one of the central challenges in today’s cataract and refractive world”, adds Dr. Nahen.
Since 25 years Heidelberg Engineering is a leader in diagnostic imaging solutions for the posterior segment. With the new cataract and refractive imaging platform the company intends to achieve the same with the anterior segment.
The cataract and refractive imaging platform fully integrates with the company’s HEYEX PACS*, the next generation Heidelberg Eye Explorer platform which provides centralized management of diagnostic images in ophthalmology.
Heidelberg, Germany – Continued Precision in Imaging from Heidelberg Engineering with Expanded Product Platform Offerings
Global ophthalmic imaging company, Heidelberg Engineering GmbH, is presenting the Widefield Imaging Module for SPECTRALIS Spectral Domain-Optical Coherence Tomography (SD-OCT) at the annual 2015 American Academy of Optometry Professional Press Conference in New Orleans, Louisiana on October 7, 2015.
The Widefield Imaging Module provides the standard field of view of a mydriatic fundus camera for all SPECTRALIS® fundus and OCT imaging modalities, simplifying diagnostic protocols and facilitating the detection of peripheral pathology.
The module provides a 55° field of view for MultiColor, BluePeak, infrared reflectance, angiography, and also OCT. Covering the macula, the optic nerve head and areas beyond the vessel arcades in a single image, the Widefield Imaging Module facilitates comprehensive diagnostics. The high-resolution, high-contrast scanning laser images captured with this SPECTRALIS module offer diagnostic capabilities superior to conventional fundus photography.
Fundus imaging in combination with OCT have become indispensable technologies for eye care professionals, aiding in the diagnosis and follow-up of patients with a variety of diseases including glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy.
The Widefield Imaging Module is one of the latest additions to the SPECTRALIS system, an expandable diagnostic imaging platform that combines scanning laser fundus imaging with high-resolution OCT.
Intraoperative swept-source OCT image acquired with the VICTUS® Femtosecond Laser Platform Heidelberg, Germany – Heidelberg Engineering has signed a new agreement with Valeant to continue to supply the swept-source OCT module for the VICTUS® Femtosecond Laser Platform, commercialized under the Bausch + Lomb / Technolas brand.
The VICTUS Femtosecond Laser Platform is used for cataract and corneal applications. Heidelberg Engineering delivers its advanced swept-source OCT module, which allows for real-time visualization during every step of the surgery, from docking through planning and treatment.
The swept-source OCT module features high quality images at video frame rate. It provides excellent imaging contrast and sensitivity for the auto-recognition of key landmarks (pupil, lens, anterior and posterior capsule), boosting surgeons’ confidence and control during surgical procedures.
“Our cooperation with Valeant to supply the OCT module for the VICTUS Femtosecond Laser Platform started four years ago. We are very pleased about its continuation because it confirms that Valeant and the users of their platform are satisfied with the performance and functionalities of Heidelberg Engineering’s technology”, said Christoph Schoess, Managing Director at Heidelberg Engineering.
Heidelberg Engineering has recently entered into a patent license agreement granting global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology.
During the congress of the ESCRS in September, Heidelberg Engineering unveiled a new swept-source OCT based cataract and refractive imaging platform*. The new platform is based on an upgradable, modular design and its main options will include: biometry for IOL calculation, corneal topography and tomography, anterior segment biometry and anterior segment imaging.
*Currently under development and not for sale yet.
Heidelberg, Germany – Celebrating its 25th anniversary at the American Academy of Ophthalmology (AAO) Meeting in Las Vegas, Heidelberg Engineering will present its latest diagnostic imaging technologies and services. For a quarter of a century, the company has been committed to delivering solutions to fundamental clinical needs in ophthalmology.
“Our focus is to offer integrated solutions that encompass state-of-the-art diagnostic imaging devices and image management solutions but also additional services such as patient and clinical education support”, said Dr. Kester Nahen, Managing Director of Heidelberg Engineering. “At the AAO we look forward to discussing with customers how established and new product platforms, IT technologies and services merge to facilitate their clinical decision making.”
Latest SPECTRALIS® modules
Heidelberg Engineering will be showcasing its state-of-the-art modules for the SPECTRALIS® Retina and Glaucoma Imaging Platform including the OCT Angiography Module*, the OCT2 Module with a high scan rate of 85,000 Hz. and the Widefield Imaging Module for simultaneous 55° fundus and OCT imaging.
New Cataract and Refractive Imaging Platform*
A new swept-source OCT-based Cataract and Refractive Imaging Platform* which was unveiled at the recent European Society of Cataract and Refractive Surgeons (ESCRS) meeting in Barcelona, will be exhibited for the first time in the United States. It allows comprehensive analyses, such as biometry for IOL calculation, corneal topography and tomography, anterior segment biometry, and anterior segment imaging. Based on an upgradable and modular design, it can be configured to meet the specific needs of the individual clinic.
Image management with HEYEX PACS*
The company’s HEYEX Picture Archiving and Communication System (PACS)* allows the seamless integration of large volumes of data and images from Heidelberg Engineering’s and other manufacturers’ devices; thus providing the ability to access, review, and compare ophthalmic diagnostic images in single as well as multi-site settings within one application.
Patient education materials and Ophthalmic Practice App
To support practitioners’ efforts to explain and promote the benefits of OCT examinations, the Heidelberg Engineering Academy will also be launching various patient education materials at the AAO, including flyers, the patient website www.know-the-eye.com and an Ophthalmic Practice App available from the iTunes App Store.
*Currently under development and not for sale yet.
Heidelberg Engineering – AAO 2015 Las Vegas, Sands Expo/Venetian, Level 2, Halls A, B & C, Booth 4215
Heidelberg, Germany – Following the company’s relocation of its U.S. headquarters to Franklin, MA, Heidelberg Engineering Inc. is pleased to announce the appointment of Ram Liebenthal as its new U.S. General Manager. Ram Liebenthal General Manager Heidelberg Engineering Inc.
Ram is an experienced medical device executive with over 20 years of expertise in sales, marketing and innovative product commercialization with large companies such as GE Healthcare and other innovative ventures.
“Under Ram’s leadership we anticipate seeing further growth in the important U.S. market, both with the introduction of new modules for the SPECTRALIS multimodal imaging platform such as the OCT Angiography Module* and with future products such as the Cataract and Refractive Imaging Platform*, and the next generation HEYEX ophthalmic image management platform*. Ram is a customer-focused, technically and commercially savvy manager very well suited for this task,” said Christoph Schoess, Managing Director of Heidelberg Engineering GmbH, parent company of Heidelberg Engineering Inc.
Ram has described enhancing the customer experience as one of his top priorities. In addition, he looks forward to developing close relationships with leading ophthalmic academic and research institutions in the Boston area, which will allow the company to continue innovating with clinically relevant diagnostic imaging solutions.
“Heidelberg Engineering’s strong tradition of product innovation and focus on long-term customer partnerships offer long-lasting value to customers. The HRT and the SPECTRALIS multimodal platforms are expandable, upgradable products built to last. That long-term focus paired with the ability to innovate with clinically relevant technologies make this company and its great team an organization I am proud and honored to lead,” said Ram Liebenthal, General Manager of Heidelberg Engineering Inc.
*Currently under development and not for sale yet.
Heidelberg, Germany – Heidelberg Engineering has reached an important corporate milestone with the 10,000th SPECTRALIS® diagnostic imaging platform, which has been delivered to a French retina specialist. Dr. David Sayag, owner of the 10,000th SPECTRALIS
For the last 25 years Heidelberg Engineering has been providing diagnostic imaging technologies which have greatly influenced ophthalmic patient care. The business has evolved from a small to a medium sized company with an increasing international footprint and an approach that brings together scientific, clinical and technological expertise to provide clinicians with high-precision diagnostic devices and IT solutions.
Sanotek, Heidelberg Engineering’s distribution partner in France, has had the pleasure of delivering the 10,000th SPECTRALIS to Dr. David Sayag, a well-known retina specialist based in Paris.
“During my professional career I have been adopting different diagnostic devices created by Heidelberg Engineering, and it was a nice surprise to find out that I had purchased the 10,000th SPECTRALIS. However, even more exciting than that are the examination results I am able to obtain with the OCT2 Module and with a prototype version of the upcoming OCT Angiography Module*. The SPECTRALIS platform keeps moving with the times!” said Dr. David Sayag.
A typical customer journey
Dr. Sayag had his first contact with Heidelberg Engineering’s technologies back in 2000, when he observed the response of feeder vessels to photodynamic therapy with indocyanin green angiographies performed with the Heidelberg Retina Angiograph (HRA). Soon after, the Hospital of Créteil, which is located near Paris and is where Dr. Sayag became a fellow, made the digital cSLO angiography part of their clinical protocol. Once the SPECTRALIS HRA+OCT was born, the ophthalmology department fully embraced its multimodal concept.
In 2007 Dr. Sayag opened a private practice in Paris specializing in AMD. He chose the SPECTRALIS HRA+OCT technology to help diagnose and monitor the hundreds of patients that ophthalmologists continue to refer to him. Over the years, he has been upgrading the platform with new modules such as the Ultra-Widefield Angiography Module, which he uses for the management of peripheral diseases like diabetic retinopathy.
The latest addition to his practice has been this “milestone” SPECTRALIS, which is equipped with the OCT2 Module, combining a high scan rate of 85,000 Hz with TruTrack Active Eye Tracking to provide excellent image quality and reduce acquisition time by 50%.
Future developments
Dr. Sayag also belongs to a group of doctors working with a prototype OCT Angiography Module*, which has allowed him to experience a sample of what many retina specialists see as a tool with very promising diagnostic potential.
“We have just celebrated our 25th company anniversary and sold our 10,000th SPECTRALIS”, said Dr. Kester Nahen, Managing Director of Heidelberg Engineering. “These kinds of milestones provide a good opportunity to think about the present, past and future. Considering the current market trends and our robust development pipeline, we are excited about our prospects and are enjoying our work just as much now as we did in the early days.”
*Currently under development and not for sale yet.
Heidelberg, Germany – Alex Huang, MD, PhD, is the winner of the Heidelberg Engineering Xtreme Research Award 2016 for his research on aqueous angiography and OCT structural analysis of outflow pathways. He received the award in a ceremony during ARVO’s Annual Meeting in Seattle.
Dr. Huang, who is a glaucoma clinician scientist at the Doheny Eye Institute and at the Department of Ophthalmology of the David Geffen School of Medicine at UCLA in Los Angeles, presented the highlights of his current research in an outstanding lecture titled “To See and Touch Aqueous Humor Outflow”.
With the annual Xtreme Research Award, Heidelberg Engineering intends to honor the most cutting-edge research for the advancement of ophthalmic care. This year, the award went to Dr. Huang in recognition for his latest research initiative on structure and function of the anterior segment consisting of a novel method referred to as “aqueous angiography”, which involves dye-based angiography of the anterior chamber and OCT imaging of the outflow pathways using a multimodal imaging platform.
Although still in its early stages, Dr. Huang’s research intends to improve glaucoma angle-based procedures by guiding its placement according to the individual anatomy of each eye. For example, stent location in minimally invasive glaucoma surgery (MIGS) is believed to have an influence on the outcome of the procedure. If this hypothesis is proven true, customization of the stent’s position guided by the characteristics of each eye could lead to improved surgery outcomes.
“We are genuinely excited about future possibilities and potential clinical impact that structural and functional anterior segment imaging such as aqueous angiography may have on glaucoma and ophthalmology. With these tools, one day we may start tailoring glaucoma care to an individual patient’s anatomy or patterns of aqueous humor outflow. Thus, this is a real opportunity to learn new biology of the eye as well as push the efficacy of patient care forward”, said Dr. Huang.
“Looking ahead, we would like to provide a diagnostic imaging platform to perform dye-based angiography of the anterior segment pre- or intra-operatively and for this reason, we are enthusiastic about Dr. Huang’s research project. Such novel applications of anterior segment research could provide clinically valuable information about aqueous humor flow and flow patterns leading to more effective glaucoma treatment”, said Dr. Kester Nahen, Managing Director of Heidelberg Engineering.
With that purpose, Heidelberg Engineering’s development team supports Dr. Huang and other leading clinicians eager to improve glaucoma treatment outcomes by developing novel anterior segment analyses that combine both the structural and functional aspects using high-end diagnostic imaging equipment.
Dr. Alex Huang receives the Xtreme Research Award 2016 from Dr. Kester Nahen, Managing Director of Heidelberg Engineering.
Aqueous angiography demonstrating aqueous humor outflow starting from peri-limbal structures (asterisk; trabecular meshwork, Schlemm’s Canal, and collector channels) to a distal episcleral veins (arrows). Segmental flow is seen in peri-limbal areas without outflow (arrowhead).
Heidelberg, Germany — At the meetings of the European Society of Retina Specialists (EURETINA) and European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen from September 9th to 13th Heidelberg Engineering seeks to engage in a dialog about smart multimodal imaging.
Heidelberg Engineering’s presence at ESCRS and EURETINA focuses on the advantages of smart multimodal imaging. In addition to lunch symposia, Heidelberg Engineering will offer short, interactive in-booth presentations about both novel and established diagnostic tools designed to support clinical decision-making.
Among the innovation highlights this year are the latest SPECTRALIS® modules, the new Cataract and Refractive Imaging Platform* and the next generation HEYEX* for ophthalmic image management and device integration. ESCRS/EURETINA is also the occasion chosen for the international launch of the Heidelberg Engineering Business Lounge, an exclusive portal for ophthalmology professionals.
“Clinical practice keeps proving the importance of multimodal imaging in comprehensive diagnostics. In this context we would like to take the discussion further to the concept of smart multimodality imaging: Which imaging modalities make the most sense for specific patients and pathologies? How can they be integrated into a solid and convenient IT infrastructure? We are looking forward to discussing these topics with customers”, said Dr. Kester Nahen, Managing Director of Heidelberg Engineering.
Heidelberg Engineering Flex Module
Retina
The Flex Module* for the SPECTRALIS imaging platform will be shown in Copenhagen for the very first time. With its movable stand and an adjustable, flexible arm, the Flex Module enables all SPECTRALIS examinations to be performed on patients lying down in the supine position.
While the Flex Module offers a solution for a very specific clinical set-up, the new OCT2 Module can benefit every SPECTRALIS user. With its high scan rate of 85,000 Hz, this module cuts acquisition time by half and delivers excellent image quality. Additionally, the OCT2 Module provides an ideal platform for future advanced applications such as the OCT Angiography Module*.
For easier detection of peripheral pathologies, the Widefield Imaging Module with its simultaneous 55° fundus and OCT imaging is a very useful tool for retina specialists and general ophthalmologists. The high-resolution, high-contrast scanning laser images captured with this SPECTRALIS module offer diagnostic capabilities beyond those of conventional fundus photography.
Glaucoma
The Glaucoma Module Premium Edition provides a comprehensive analysis of the optic nerve head, retinal nerve fiber layer, and ganglion cell layer by precisely matching unique scan patterns to the fine anatomic structures relevant in glaucoma diagnostics. This glaucoma module compares patients’ eyes to a reference database of normal eyes, noting even very small deviations. The precision of the SPECTRALIS AutoRescan function allows confident identification and monitoring of structural changes from visit to visit.
The speed achieved with the SPECTRALIS OCT2 Module is a great enhancement to the Glaucoma Module Premium Edition. Images are acquired twice as fast as in the past and their quality is also better than with the previous OCT engine due to a high scan rate of 85,000 Hz combined with the TruTrack Active Eye Tracking developed exclusively by Heidelberg Engineering.
Cataract and refractive
The Cataract and Refractive Imaging Platform* utilizes high-resolution, swept-source OCT images to combine the most important examinations for anterior segment diagnostics in one modular, upgradeable system: Topography, tomography, anterior segment biometry and axial length in one workflow-efficient device.
Its key benefits are:
All measurements based on high-resolution swept-source OCT images,
Modular and upgradeable platform to suit different workflow needs,
Supported by the next generation HEYEX* for effective image management and IT integration.
Ophthalmic image management and device integration with the new HEYEX*
As the next generation ophthalmic image management and device integration software module from Heidelberg Engineering, HEYEX is an integral part of all Heidelberg Engineering products. The HEYEX module networks all devices and makes it possible to review examination results simultaneously and interactively. It interfaces with electronic medical record (EMR) systems and third-party devices to allow the secure exchange, storage, and dynamic review of images in a single, centralized IT solution even across different sites.
Launch of the Heidelberg Engineering Business Lounge
With the international launch of this new customer portal, Heidelberg Engineering brings premium digital ophthalmology content by experts for experts. Following a quick registration process, users have access to a wealth of detailed product information and support materials such as e-learning materials, case studies or e-books. Live demonstrations will be provided at the booth during EURETINA/ESCR. For more information please visit: www.he-lounge.com
Symposia and in-booth presentations
Heidelberg Engineering will host a lunch symposium at EURETINA and another one at ESCRS as well as a variety of in-booth presentations:
Lunch symposium at EURETINA:
“Multimodal Imaging of Geographic Atrophy”
Friday, Sept 9 (13:00 – 14:00)
Auditorium A3
Speakers: Giovanni Staurenghi (Italy), Steffen Schmitz-Valckenberg (Germany), SriniVas R. Sadda (USA)
Lunch symposium at ESCRS
“Smart Multimodality Imaging & Quiz”
Sunday, Sept 11 (13:00 – 14:00)
Room B10
Speakers: Yit Yang (United Kingdom) – OCT Angiography – Reality Update; Marco Pellegrini (Italy) – Smart Multimodality Imaging
Topics and schedule of 20-minute in-booth presentations:
Update on OCT angiography
Bruch’s Membrane Opening (BMO) and Optic Nerve Head (ONH) anatomy
Interpretation of MultiColor images
OCT interpretation in glaucoma
Fundus autofluorescence imaging in geographic atrophy (GA)
Heidelberg, Germany – The Glaucoma Module Premium Edition adds diagnostic capabilities to Heidelberg Engineering’s SPECTRALIS® OCT imaging platform. The module provides clinicians with several objective and automated measurement parameters to deliver increased diagnostic accuracy.
The Glaucoma Module Premium Edition for SPECTRALIS provides a comprehensive analysis of the optic nerve head, retinal nerve fiber layer, and ganglion cell layer by precisely matching unique scan patterns to the fine anatomic structures relevant in glaucoma diagnostics.
By means of a new proprietary technology called the Anatomic Positioning System, the module creates an anatomic map unique to each patient’s eye using two fixed, structural landmarks: the center of the fovea and the center of Bruch’s membrane opening. All subsequent scan protocols are automatically oriented according to each eye’s unique anatomic map, enabling a precise examination of relevant structures over time.
Furthermore, the Glaucoma Module Premium Edition compares patients’ eyes to an age- and disc size-adjusted reference database of healthy eyes representing the racial and ethnic mix of the US population, flagging small deviations that may be clinically relevant. This allows for a highly sensitive assessment of structural damage characteristic of glaucoma and a close monitoring of structural changes indicative of glaucomatous progression.
The physiological and technical premise of the Glaucoma Module Premium Edition is based on research collaborations between two groups led by Balwantray C. Chauhan, Ph.D., Dalhousie University in Halifax (Canada), and Claude F. Burgoyne, M.D., Devers Eye Institute in Portland, OR (USA) performed with the SPECTRALIS imaging platform1,2,3,4,5,6. Their work revealed the importance of making an anatomically and geometrically accurate neuroretinal rim measurement using Bruch’s membrane opening, the anatomical outer border of the rim.
“The measurements are more accurate because they are based on an identifiable anatomical border of the rim and take into account its varying geometry at the point of measurement”, said Dr. Burgoyne. Dr. Chauhan added: “We have already been able to demonstrate that the use of this new measurement method translates into significantly enhanced diagnostic accuracy.”
“The 510(k) clearance of this product is great news for our company and also for glaucoma patients in the U.S. The Glaucoma Module Premium Edition is an excellent tool to assess glaucomatous damage based on a novel objective examination of the optic nerve head anatomy”, summarizes Dr. Gerhard Zinser, Managing Director of Heidelberg Engineering.
Analysis of the optic nerve head with Heidelberg Engineering’s SPECTRALIS® Glaucoma Module Premium Edition
References:
Chauhan B.C. et al., Ophthalmology, 2013;120:535–543.
Chauhan B.C. and Burgoyne C.F., Am J Ophthalmol. 2013;156:218-227.
Chauhan B.C. et al.,Ophthalmology, 2015;122:1786-1794.
He L. et al., PLoS One, 2014;9:e92225.
Reis A.S.et al., Ophthalmology, 2012;119:738–747.
Reis A.S. et al., Invest. Ophthalmol. Vis. Sci., 2012;53:1852–1860.
At the American Academy of Ophthalmology (AAO) Meeting in Chicago from October 15th to 18th, Heidelberg Engineering invites attendees to discover the future of personalized glaucoma management.
Heidelberg, Germany – Heidelberg Engineering is pleased to announce the launch of the recently FDA cleared SPECTRALIS OCT Glaucoma Module Premium Edition during the 2016 American Academy of Ophthalmology (AAO) Meeting in Chicago, IL.
The SPECTRALIS OCT Glaucoma Module Premium Edition provides a comprehensive analysis of the optic nerve head, retinal nerve fiber layer, and ganglion cell layer by precisely matching unique scan patterns to the fine anatomic structures relevant in glaucoma diagnostics.
The proprietary Anatomic Positioning System (APS) creates an anatomic map of each patient’s eye using two fixed, structural landmarks: the center of the fovea and the center of Bruch’s membrane opening. With APS, all scan protocols are automatically oriented to the patient‘s anatomic map. This enables precise examination of relevant structures and ensures accurate comparisons with reference data, allowing for a highly sensitive assessment of structural change.
“We are excited to be able to share this technology with the U.S. market,” said Ram Liebenthal, U.S. General Manager of Heidelberg Engineering. “We believe the Glaucoma Module Premium Edition offers an important new piece of the puzzle in evaluating patients for glaucomatous change, and we hope everyone will join us at AAO to learn more and celebrate the future of personalized glaucoma management.”
Educational Session
Heidelberg Engineering will host an educational session about the new glaucoma module entitled “Enhanced Detection and Clinical Assessment in Glaucoma Management” on Sunday, October 16th, at 3:30 PM in the Technology Pavilion on the exhibit floor. The presentation will include guest lectures from Chris Girkin, MD, University of Alabama – Birmingham, Donald Hood, PhD, Columbia University, and Felipe Medeiros, MD, PhD, University of California – San Diego.
Launch Party Reception
The dialogue will continue Sunday evening from 6:30-9:30 PM at the top of the AON building, where the company will hold a launch party reception. The guest lecturers from the educational session will be on hand to answer questions and discuss how to optimize glaucoma detection and progression assessment with the SPECTRALIS OCT. Those wishing to attend are encouraged to register for the event at https://bit.ly/GMPELaunchParty.
Please note that the events listed in this press release are not affiliated with the official 2016 AAO Program.
Analysis of the optic nerve head with Heidelberg Engineering’s SPECTRALIS® Glaucoma Module Premium Edition
Heidelberg Engineering is showcasing the OCT Angiography (OCTA) Module for its SPECTRALIS® diagnostic imaging platform at the American Academy of Ophthalmology Annual Meeting in Chicago. The OCT Angiography Module non-invasively produces detailed three-dimensional representations of the perfused retinal and choroidal vasculatures.
Heidelberg, Germany – The SPECTRALIS® expandable diagnostic imaging platform can be upgraded with the OCT Angiography Module to perform non-invasive, layer-by-layer examinations of flow in the vascular networks of the retina and choroid. Combined with structural OCT and fluorescence angiography, the OCT Angiography Module enables a more comprehensive understanding of vascular abnormalities.
The OCT Angiography Module can be added to new and existing upgradeable SPECTRALIS devices with the OCT2 Module. The multimodal imaging platform allows clinicians to compare OCT angiographies to other modalities such as structural OCT and dye-based angiographies as well as infrared, MultiColor and BluePeak images, dependent on the SPECTRALIS model.
High resolution for precise vascular details
SPECTRALIS offers high resolution OCT angiography with a lateral 6 microns per pixel for visualization of capillaries. An axial resolution of 3.9 microns per pixel enables precise multilayer segmentation. All four vascular plexuses of the retina as described by Tan et al.1 (located in the nerve fiber layer, in the ganglion cell layer, at the border of the inner plexiform layer and inner nuclear layer, and at the border of the inner nuclear layer and outer plexiform layer) can be investigated. Like all SPECTRALIS diagnostic imaging modalities, the OCT Angiography Module benefits from the precision of TruTrack Active Eye Tracking which avoids motion artifacts and ensures high resolution images.
Hybrid angiography
Hybrid angiography with SPECTRALIS high-resolution OCT Angiography Module identifies vascular detail and correlates it with dye-based angiography. Left to right: FA, OCTA and IR images.
The SPECTRALIS platform offers a unique combination of non-invasive OCT angiography with dye-based, gold-standard fluorescein (FA) or indocyanine green (ICGA) scanning laser angiography. With this hybrid angiography approach, OCTA images can be directly correlated pixel to pixel to FA or ICGA, setting a baseline for subsequent OCTA-only follow-up examinations. The Scan Planning Tool automates OCTA scan placement on a region of interest identified on FA/ICGA or any other previously-acquired cSLO image. Such reference images can originate from the same or another SPECTRALIS device. With the convergence of established and emerging imaging techniques, the SPECTRALIS platform supports the understanding and adoption of new diagnostic tools such as OCTA in routine clinical practice.
“There is a great deal of interest in OCTA and at the same time uncertainty due to its technical limitations and interpretation challenges. We see multimodal imaging as a good approach to deal with those issues. For instance, OCTA is a valuable imaging modality to follow up on an existing FA, and our SPECTRALIS platform offers the possibility to do exactly that,” said Dr. Kester Nahen, Managing Director of Heidelberg Engineering.
OCTA technology and SPECTRALIS
The OCTA module of the SPECTRALIS uses a complex mathematical model fed by full spectrum OCT data. The full spectrum approach enables three-dimensional OCTA imaging with high axial resolution separating thin vascular plexuses. The mathematical model is highly sensitive and allows the visualization of small changes between consecutive OCT scans representative of vascular flow. This method results in high contrast between areas of vascular flow and surrounding tissue.
The SPECTRALIS is an ophthalmic imaging platform with an upgradable, modular design. This platform allows clinicians to configure each SPECTRALIS to the specific diagnostic workflow in the practice or clinic. Options include: OCT, multiple scanning laser fundus imaging modalities, widefield and ultra-widefield modules, scanning laser angiography and OCT angiography.
Availability
The OCT Angiography Module is not for sale in the United States. Heidelberg Engineering will deliver the OCTA Module to customers outside the U.S. in November 2016.
1 Priscilla Ern Zhi Tan, Invest Ophthalmol Vis Sci. 2012;53:5728–5736
Dr. Gerhard Zinser (right) receives the Founders’ Award from Dr. John Flanagan, one of the founders of the Optometric Glaucoma Society. Photo: Andie Petkus Photography.
Heidelberg, Germany – Dr. Gerhard Zinser, co-founder and Managing Director of Heidelberg Engineering, is the first non-clinician to be honored with this prestigious award. Earlier this year he was also elected as part of The Ophthalmologist’s Power List of the top 100 most influential people in ophthalmology.
The Founders’ Award was handed over by Dr. John Flanagan, one of the founders of the Optometric Glaucoma Society, during the society’s Annual Scientific Meeting in Anaheim, CA, on November 8th.
In his laudatory speech, John Flanagan, OD, PhD, (Dean School of Optometry, UC Berkeley, CA) emphasized Dr. Zinser’s significant and long-standing contribution to diagnostic imaging in eye-care with innovative and reliable devices which have turned into household names for eye-care specialists worldwide. Dr. Flanagan summarized the achievements of Dr. Zinser and Heidelberg Engineering dating back to the launch of the first diagnostic imaging device geared towards glaucoma diagnostics in 1991, the Heidelberg Retina Tomograph (HRT). Dr. Flanagan reminded the audience also of the tremendous impact on eye-care of the most current contribution of Heidelberg Engineering, the multimodal SPECTRALIS imaging platform.
“I am honored to receive this award and accept it in the name of the whole Heidelberg Engineering team”, said Dr. Gerhard Zinser.
Since the establishing of the Optometric Glaucoma Society, the Founders’ Award has only been awarded to three clinician scientists, all of them glaucoma research luminaries: Douglas R. Anderson, MD (Bascom Palmer, Miami, FL) received the honor in 2011, Robert N. Weinreb, MD (Shiley Eye Institute, UC San Diego, CA) received the honor in 2012 and Harry A. Quigley, MD (Johns Hopkins, Baltimore, MD) in 2015.
Power List 2016
Earlier this year the readers of the journal The Ophthalmologist voted for Dr. Gerhard Zinser to be part of its Power List 2016, as one of the top 100 most influential people in the world of ophthalmology for the second consecutive time. According to a nominator quoted by The Ophthalmologist: “He is responsible for several of the major diagnostic imaging innovations in ophthalmology. Further, he is actively involved in cutting-edge research and in sponsoring innovative activities that will translate into major products in the coming decade.”
For the employees and distribution partners of Heidelberg Engineering, the recognition awarded to Dr. Zinser’s achievements is an encouragement to continue bringing innovative diagnostic devices and IT solutions to eye-care specialists around the world.
About the Optometric Glaucoma Society (OGS)
The Optometric Glaucoma Society´s mission is to encourage excellence in care of glaucoma patients through education and scientific investigation. The main goals of the OGS are to promote the education of optometrists, the acquisition of new knowledge about glaucoma and much more.
The SPECTRALIS OCT Angiography Module non-invasively produces detailed, three-dimensional representations of the perfused retinal and choroidal vasculatures.Heidelberg Engineering has started delivering the OCT-Angiography Module to SPECTRALIS® customers outside the United States. The OCT Angiography Module non-invasively produces detailed three-dimensional representations of the perfused retinal and choroidal vasculatures.
Heidelberg, Germany – The SPECTRALIS® expandable diagnostic imaging platform can be upgraded with the OCT Angiography Module to perform non-invasive, layer-by-layer examinations of flow in the vascular networks of the retina and choroid.
The OCT Angiography Module can be added to new and existing upgradeable SPECTRALIS devices with the OCT2 Module. The multimodal imaging platform allows clinicians to compare OCT angiographies to other modalities such as structural OCT and dye-based angiographies as well as infrared, MultiColor and BluePeak images, dependent on the SPECTRALIS model.
“In combination with other imaging modalities, OCT angiography enables a more comprehensive understanding of vascular abnormalities. The SPECTRALIS truly integrates OCTA with other clinically well-established imaging modalities to facilitate for instance direct, pixel-to-pixel OCTA follow-ups on an existing FA,” said Dr. Kester Nahen, Managing Director of Heidelberg Engineering.
High resolution for precise vascular details
SPECTRALIS offers high resolution OCT angiography with a lateral 5.7 microns per pixel for visualization of capillaries. An axial resolution of 3.9 microns per pixel enables precise multilayer segmentation. All four vascular plexuses of the retina as described by Tan et al.1 (located in the nerve fiber layer, in the ganglion cell layer, at the border of the inner plexiform layer and inner nuclear layer, and at the border of the inner nuclear layer and outer plexiform layer) can be investigated. Like all SPECTRALIS diagnostic imaging modalities, the OCT Angiography Module benefits from the precision of TruTrack Active Eye Tracking which avoids motion artifacts and ensures high resolution images.
1 Priscilla Ern Zhi Tan, Invest Ophthalmol Vis Sci. 2012;53:5728–5736
Arianna Schoess, newly appointed Managing Director of Heidelberg Engineering GmbH.Heidelberg Engineering GmbH, the ophthalmic imaging solutions company, has appointed Arianna Schoess as Managing Director. In her new role, she joins the two company founders, Dr. Gerhard Zinser and Christoph Schoess, and Dr. Kester Nahen in the Board of Directors.
Heidelberg, Germany – Arianna Schoess joined Heidelberg Engineering in 2013 and has since been instrumental in the acquisition of the IT company Medical Communications and the reorganization of Heidelberg Engineering Inc. in connection with its relocation from the US West to the East Coast. In the USA, she serves as Chairman of the Board and in Switzerland as Managing Director of the subsidiary in Zurich. She has been responsible for Human Resources since early 2016, and in her new role she will dedicate herself to supporting Heidelberg Engineering’s solid international growth path through product innovations and partnerships.
Arianna received an international education in economics and business administration at universities in Friedrichshafen (Germany), Moscow (Russia) and Zurich (Switzerland). Before joining Heidelberg Engineering, she worked at a medical start-up company and as an investment manager at a Zurich-based private equity company.
“Arianna’s great motivation, her experience with investments, and her entrepreneurial spirit will surely help our company reach our growth goals”, said Dr. Gerhard Zinser, founder and Managing Director of Heidelberg Engineering.
“The company’s founders and the whole team have made Heidelberg Engineering one of the most respected and innovative companies in the ophthalmic industry. I look forward to working closely with our team to continuously refine our strategy, adapting it to the changing needs of the market to maintain our leadership position in the ophthalmology field”, said Arianna Schoess.
In the last 25 years, Heidelberg Engineering has evolved from a small to a leading medium-sized company in the field of ophthalmic diagnostic imaging and IT healthcare solutions. Its business strategy has been creating clinically relevant diagnostic solutions by applying cutting-edge technologies. Eye care specialists worldwide use Heidelberg Engineering’s devices – including the SPECTRALIS® imaging platform − for the diagnosis and monitoring of pathologies such as glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema.
Heidelberg Engineering and its long-time distribution partner in China, Gauss Medical Corporation, have established a joint venture for the supply of healthcare IT solutions to the Chinese ophthalmology market.
Heidelberg, Germany – The joint venture company, Gauss Infomed, will offer Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) software, along with other related product solutions for the ophthalmology healthcare IT market. Gauss Infomed will operate out of Beijing and through a local network of offices to deliver its services across the entire country.
“The establishment of this joint venture with Heidelberg Engineering comes at a time of growing demand for advanced ophthalmic IT solutions in China,” said Mr. Liu Xidong, Chairman and CEO of Gauss Infomed. “Heidelberg Engineering is an ideal partner in our efforts to meet that demand. Ophthalmologists in China tremendously value Heidelberg Engineering’s high-quality imaging products, such as the SPECTRALIS OCT platform, and I am confident they will also appreciate our comprehensive ophthalmic IT solutions, exclusively offered through Gauss Infomed”.
In addition to its role as a shareholder, Heidelberg Engineering will contribute to the joint venture with its extensive expertise as developer of high-tech diagnostic imaging platforms as well as with its next generation HEYEX software, which offers modern ophthalmic image management and device integration capabilities.
HEYEX is an integral part of all Heidelberg Engineering products, which networks ophthalmic devices and makes it possible to review examination results simultaneously and interactively. HEYEX also interfaces with Electronic Medical Record (EMR) systems and third-party devices to allow for the secure exchange, storage, and dynamic review of images in a single, centralized IT solution across multiple sites.
“China is a fast-growing market and it is of great importance to our company,” said Arianna Schoess, Managing Director at Heidelberg Engineering. “Our excellent partnership with Gauss Medical Corporation − spanning nearly two decades − has led to the widespread adoption of our diagnostic imaging platforms by eye care professionals in China. The establishment of this healthcare IT joint venture is, therefore, a natural next step for us in further increasing our presence and footprint in this important market.”
“Ophthalmic healthcare IT is a growing business and focus area for our company,” said Kfir Azoulay, Head of Strategy at Heidelberg Engineering and the appointed Director to the Board of Gauss Infomed. “With the establishment of this joint venture, Heidelberg Engineering is poised to become a leading provider of ophthalmic healthcare IT solutions in China.”
Heidelberg Engineering anticipates the demand for healthcare IT solutions in the ophthalmic sector to grow significantly not only in China but also in the rest of the world. The company has specific plans for its new HEYEX software to be rolled out globally during the coming months and years. Those plans include offering HEYEX to customers through its network of subsidiaries but also through its distribution partners and other potential partnerships.
While ophthalmic IT solutions will play an increasingly important role in Heidelberg Engineering’s product portfolio, the company will continue to focus on the development of state-of-the-art imaging platforms for eye care professionals.
The next generation HEYEX software in a dual monitor setup: The monitor on the left shows the navigator screen with the versatile data management tools. The one on the right shows the multi-modality viewer with an automatic layout for BluePeak autofluorescense images to efficiently visualize structural changes over time.
Heidelberg, Germany – Heidelberg Engineering GmbH today announced that it has acquired 100% ownership of Medisoft Limited, the leading UK-based provider of Electronic Medical Records (EMR) software solutions for the ophthalmology market.
In healthcare IT, Heidelberg Engineering already offers comprehensive ophthalmic image management and other data solutions that address the requirements of enterprises as well as private practices. The company has also recently announced the establishment of an ophthalmic healthcare IT joint-venture in China with its long-time local business partner.
“Over the past 20 years, the Medisoft team has been dedicated to delivering an ophthalmology EMR that is easy and quick to use by ophthalmologists and other eye-care professionals, and that delivers detailed analysis of medical and surgical treatment outcomes,” said David Johnston, co-founder and Chairman of Medisoft. “Joining forces with Heidelberg Engineering and its broad portfolio of diagnostic imaging systems, image management solutions, and global reach will offer Medisoft a solid platform to accelerate further business growth outside the UK – enabling ophthalmology departments and private practices access to both patient records and their associated images using a combined offering from the two companies.”
“The acquisition of Medisoft brings together a highly experienced team and market-proven EMR capabilities with Heidelberg Engineering’s expertise in image management and diagnostic imaging systems,” said Christoph Schoess, Managing Director at Heidelberg Engineering GmbH. “We look forward to working with the Medisoft team to provide our customers with an increasingly wider range of ophthalmic healthcare IT solutions.”
Medisoft will continue operating out of its headquarters in Leeds, UK. Further, as part of this transaction, Heidelberg Engineering has appointed Arianna Schoess and Kfir Azoulay to the Board of Directors of Medisoft, in addition to current Board members David Johnston, Christian Martin, and Alice Braga Johnston.
“We expect to significantly strengthen our ophthalmic healthcare IT business with this strategic acquisition,” said Kfir Azoulay, Head of Strategy at Heidelberg Engineering. “Incorporating Medisoft’s advanced ophthalmic EMR product to our portfolio will enable the release of comprehensive software solutions that bring disparate data together and significantly improve patient care as well as operational efficiencies for our customers.”
While ophthalmic IT solutions will play an increasingly growing role in Heidelberg Engineering’s portfolio, the company will continue focusing on its core business of state-of-the-art diagnostic imaging platforms for eye-care professionals.
Through the acquisition of Medisoft, Heidelberg Engineering has expanded its healthcare IT portfolio with advanced EMR solutions (left monitor) that complement the HEYEX Platform for Ophthalmic Image Management and Device Integration.
2017 Xtreme Research Award winner Dr. Massimo Fazio (left) and 2016 winner Dr. Alex Huang.Heidelberg, Germany – Massimo Fazio, PhD, a biomechanics and mechanobiology researcher at the Department of Ophthalmology in the University of Alabama at Birmingham (UAB) received the award at an event held by Heidelberg Engineering during ARVO’s Annual Meeting in Baltimore.
Dr. Fazio has a background in mechanical engineering, and as part of the UAB Ocular Biomechanics and Mechanobiology group his work primarily focuses on developing advanced image processing algorithms and custom optical devices in order to investigate the biomechanics and morphology of ocular tissue in glaucoma and myopia.
At the award ceremony, Dr. Fazio presented a riveting lecture entitled “In-vivo Quantification of Biomechanics and Morphometry across Ocular Disease”, which illustrated how custom methods of image analysis combined with unique imaging modalities are applied to human and animal models. These methods set the stage for novel imaging tools that may aid in the diagnosis of various ocular diseases.
With the annual Xtreme Research Award, Heidelberg Engineering intends to honor cutting-edge research for the advancement of ophthalmic care. This year, Dr. Fazio’s work was recognized for its contribution to identifying novel imaging biomarkers that take into account the dynamic biomechanical response of ocular tissues to intraocular pressure. This response is thought to be involved in the pathogenesis of glaucoma and myopia.
Although still in its early stages, Dr. Fazio’s research aims to develop imaging methods that can enhance the current OCT-based diagnostic parameters and offer customized analyses that may be predictive of future damage. One such method is the use of a simple and quick image scanning protocol that can assess each eye’s unique mechanical response by the optic nerve head to IOP changes. The evaluation of such changes offers shear strain values that may be indicative of the eye’s susceptibility to damage due to diurnal IOP variations and of future visual field loss. If this hypothesis is proven true, customized measurements of characteristics such as retinal nerve fiber layer, lamina cribrosa shifts, and peripapillary sclera changes could lead to improved glaucomatous OCT parameters and diagnostically sensitive predictive factors.
“The imaging capabilities achieved by the SPECTRALIS OCT allowed us to visualize and quantify the complex biomechanical behavior of ocular tissue in-vivo and in real-time. This quantification has never been done before. Quantitative eye-specific analyses that were only achievable in a research environment are soon going to be transferred to daily clinical practice. I believe that with the widespread use of new OCT technologies, we’ll soon witness a radical shift on how we diagnose and treat debilitating ocular diseases”, said Dr. Fazio.
“Moving forward, we would like to provide a diagnostic imaging platform to offer a suite of diagnostic parameters that extend beyond static measures and are customized to each eye’s unique anatomy. We are excited about Dr. Fazio’s research project and hope that such tools will enable clinicians to better predict their diagnostic and treatment outcomes, offering the opportunity to make more informed decisions with higher clinical confidence,” said Ali Tafreshi, Director of Clinical Research, Heidelberg Engineering.
For that purpose, Heidelberg Engineering’s Research and Development team supports Dr. Fazio and the UAB Ocular Biomechanics and Mechanobiology group as well as other leading scientists eager to enhance OCT-based diagnostic parameters. Heidelberg Engineering aims to expand its collaborative efforts with a growing number of researchers around the world to offer novel OCT-based methods geared towards individualized assessment of various ocular pathologies such as glaucoma.
Modeling of ONH deformations and associated vascular perfusion changes due to acute IOP elevation. Such models may contribute to novel diagnostic parameters that are tailored to each eye’s unique anatomy.
Heidelberg, Germany – A research group from the Centre for Public Health at the Queen’s University in Belfast, Northern Ireland, has just published the results of a study comparing SPECTRALIS® MultiColor imaging and traditional color fundus photography for the detection of features of early and late age-related macular degeneration (AMD). The study’s findings demonstrate the benefits of SPECTRALIS MultiColor imaging for increased sensitivity and specificity.
The SPECTRALIS MultiColor Module is an imaging modality which utilizes confocal scanning laser technology instead of white light to visualize the retina.The study, which was published digitally in August and will appear in the November issue of Retina, is titled: “Identifying features of early and late AMD: A comparison of MultiColor versus traditional color fundus photography”. The authors are Katie W. Graham, Usha Chakravarthy, Ruth E. Hogg, K. Alyson Muldrew, Ian S. Young and Frank Kee, all of the Centre for Public Health, Queen’s University in Belfast, Northern Ireland.
The goal of the study was to compare the MultiColor Module of the SPECTRALIS diagnostic imaging platform to color fundus photography (CFP), which is currently considered the gold standard examination for the recognition and classification of features of early and late AMD. The SPECTRALIS MultiColor Module, on the other hand, is a newer imaging modality which utilizes confocal scanning laser technology with light of discrete wavelengths instead of standard optics and white light to visualize the retina.
MultiColor was proven to have higher sensitivity than CFP for the detection of early AMD features using a sample of 105 eyes. In cases with discrepancies, an analysis of OCT also showed better agreement with MultiColor for all AMD lesions, with the exception of hemorrhage and non-geographic atrophy hypopigmentation. For pigment clumping, CFP and MultiColor were in equal agreement to OCT.
MultiColor imaging was able to identify soft drusen in 85%, reticular drusen in 83%, and atrophy and fibrosis in 100% of cases where these abnormalities were seen on CFP. However, when using MultiColor as the basis for analysis, CFP was less sensitive. In this analysis, soft drusen were identified in only 58%, reticular drusen in 28%, atrophy in 83%, and fibrosis in 68% of the cases where such changes were seen on MultiColor images.
“This systematic analysis of color fundus photography versus MultiColor demonstrated the robustness of MultiColor imaging in the detection of early AMD features. The ability to delineate atrophy and fibrosis in late stage AMD gives added value in the clinical setting, as these components of the wet AMD lesion have an important impact on visual function”, said Usha Chakravarthy, Professor of Ophthalmology and Vision Sciences at Queen’s University, Belfast, Northern Ireland.
Other clinicians also familiar with the MultiColor Module appreciate its advantages: “With the advent of MultiColor imaging we can obtain high-resolution fundus images for a precise study of the morphometric changes of the retina and combine them with structural OCT scans of up to 55 degrees. This gives us the possibility to monitor changes from visit to visit in both imaging modalities. In addition, at our clinic we can even obtain an OCTA over a MultiColor image, selecting the area of particular interest. And all of that, without having the patient moving from one system to another”, said Roberto Gallego-Pinazo, MD, Retina Specialist of the Macula Unit at Oftalvist in Valencia, Spain.
See structure at different depths
MultiColor is able to achieve such sensitivity and specificity due to its confocal scanning laser imaging technology, which uses three laser wavelengths (blue, green and infrared) simultaneously to provide diagnostic images that show distinct structures at different depths within the retina. As a result, the high-resolution MultiColor images can be used to detect and delineate structures and pathologies not visible on ophthalmoscopy and fundus photography.
MultiColor images can and should ideally be visualized both as a composite image combining all three wavelengths and also as individual blue, green and infrared reflectance images. Each of the three reflectance images offers unique details due to the penetration depth and reflectance properties of each individual wavelength used. The infrared reflectance image shows deeper structures in the choroid and the retinal pigment epithelium. The green reflectance image is useful for examining blood, blood vessels, and exudates. The blue reflectance image is best for identifying changes in superficial retinal structures, like epiretinal membranes or retinal nerve fiber layer defects.
MultiColor as part of a multimodal approach
“It is encouraging to see the clinical significance of the MultiColor Module proven in a large study related to a prevalent pathology such as AMD. Beyond the clinical value, clinicians also appreciate the fact that MultiColor images can be acquired through undilated pupils and in patients with media opacity or even nystagmus. While we don’t see MultiColor as a substitute for color fundus photography, which remains useful for documentation purposes, it is a particularly useful diagnostic tool that can be combined with other imaging modalities”, said Dr. Kester Nahen, Managing Director at Heidelberg Engineering.
Heidelberg, Germany – The company’s latest products and advancements will be shown at booth 1029 at the American Academy of Ophthalmology Annual Meeting in New Orleans, LA, November 11-14.
At this year’s AAO, Heidelberg Engineering will demonstrate how the various imaging modalities available for the SPECTRALIS® can be combined to suit the needs of an individual practice. The platform offers options including high resolution OCT2, MultiColor, BluePeak autofluorescence, widefield and ultra-widefield imaging, and scanning laser angiography.
“The flexibility and upgradeability of the SPECTRALIS allow it to meet the diagnostic imaging needs of all types of clinical practices, regardless of size or specialty,” said Ram Liebenthal, General Manager of Heidelberg Engineering Inc. “Our goal is to help our customers optimize their workflow with a SPECTRALIS that has the modules they need to address the specific demands of their practice.”
Among the innovation highlights this year are the latest SPECTRALIS modules, including OCT2, and HEYEX 2, the company’s new platform for ophthalmic image management and device integration.
HEYEX 2
With a modern user interface and state-of-the-art database, HEYEX 2 offers a comprehensive platform for imaging and data management. By networking Heidelberg Engineering devices within a practice and across multiple practice locations, HEYEX 2 enables fast and simultaneous review of examination results for improved clinical workflow. Interfacing with electronic medical record (EMR) systems allows for the secure exchange, storage, and dynamic review of diagnostic images in a single, centralized IT solution. With its scalable architecture, HEYEX 2 furthers Heidelberg Engineering’s mission to offer sustainable platforms that can grow along with a practice.
Glaucoma Atlas Preview
At last year’s AAO, the company launched its Glaucoma Module Premium Edition for the SPECTRALIS in the U.S. This module provides a comprehensive analysis of the optic nerve head, retinal nerve fiber layer, and ganglion cell layer by precisely matching unique scan patterns to the fine anatomic structures relevant in glaucoma diagnostics. At this year’s meeting, the company will share a preview of the in-depth Glaucoma Atlas currently in development with clinicians across the country and around the world. Over 30 clinical cases from six different countries will be included in the final book, which will focus on all aspects of glaucoma diagnosis and management. Complimentary copies of the Glaucoma Atlas preview, which contains three cases from the Atlas, will be available at the booth.
Enter to Win a Free Widefield Imaging Module
Visitors to Heidelberg Engineering’s booth will also have the opportunity to win a free Widefield Imaging Module for the SPECTRALIS. The Widefield Imaging Module provides a 55-degree field of view for all SPECTRALIS fundus imaging modalities including MultiColor, BluePeak, infrared reflectance and angiography. Capturing the macula, the optic nerve head, and areas beyond the vessel arcades in a single image, the Widefield Imaging Module facilitates comprehensive diagnostics. The high-resolution, high-contrast scanning laser images captured with this SPECTRALIS module offer diagnostic capabilities beyond those of conventional fundus photography. The giveaway is open to all AAO attendees.
The SPECTRALIS from Heidelberg Engineering offers multiple imaging modalities on a single device.
Heidelberg, Germany – Heidelberg Engineering announces with great sadness the untimely passing of the company’s co-founder and Managing Director, Dr. Gerhard Zinser, on November 19, 2017.
Dr. Gerhard Zinser, co-founder and Managing Director of Heidelberg Engineering GmbH.
Dr. Gerhard Zinser was a pioneer, an inventor, and the driving force behind many of Heidelberg Engineering’s groundbreaking technologies and products, such as the Heidelberg Retina Tomograph (HRT) and the SPECTRALIS platform. Ever the quintessential scientist, his considerable contributions to the field of ophthalmology and optometry could only be matched by his humility and generosity.
“I have had the privilege of working with Gerhard for nearly three decades in an exceptionally harmonious partnership. He will be sorely missed by all of us here at Heidelberg Engineering, and we are steadfast in our commitment to continue his lifelong mission of bringing innovation to the field of eye care for many more years to come.” said Christoph Schoess, Co-Founder and Managing Director of Heidelberg Engineering GmbH.
The thoughts of the management and employees of the entire Heidelberg Engineering group go out to Dr. Zinser’s wife and loved ones.
Heidelberg Engineering invites all those who have collaborated with Dr. Zinser over the years to share their thoughts and sympathies via the following email address: condolences@heidelbergengineering.com
